Biostar Pharmaceuticals, Inc.
BSPM
Rank in Stocks
#35247
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets... Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. In addition, the company provides prescription pharmaceutical products, including Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. It sells its products through distributors and website that serves as internet-based China Hepatitis Internet Hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Share Price
$0.0001
Last synced: 2026-11-06
Market Cap
$264.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Biostar Pharmaceuticals, Inc. (BSPM)
Category
Healthcare
Operating Margin for Biostar Pharmaceuticals, Inc. (BSPM)
Operating Margin as of November 2026 TTM: -149.50%
According to Biostar Pharmaceuticals, Inc.'s latest financial reports, its current operating margin (TTM) is -149.50%. At the end of 2016 the company had an operating margin of -149.50%.
Operating Margin history for Biostar Pharmaceuticals, Inc. from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -149.50% | 0.00% |
| 2016 | -149.50% | 70.72% |
| 2015 | -87.57% | 3,992.06% |
| 2014 | -2.14% | -322.92% |
| 2013 | 0.96% | -102.35% |
| 2012 | -40.93% | -307.24% |
| 2011 | 19.75% | -32.89% |
| 2010 | 29.43% | 3.92% |
| 2009 | 28.32% | 23.72% |
| 2008 | 22.89% | -24.95% |
| 2007 | 30.50% | -1.71% |
| 2006 | 31.03% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.13% |
DE
|
|
| 19.68% | -100.13% |
DE
|
|
| 13.26% | -100.09% |
JP
|
|
| 17.08% | -100.11% |
CH
|
|
| 14.92% | -100.10% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Biostar Pharmaceuticals, Inc.'s operating margin
What is Biostar Pharmaceuticals, Inc.'s operating margin?
Biostar Pharmaceuticals, Inc.'s operating margin is -149.50%, as of Nov 2026.
What was Biostar Pharmaceuticals, Inc.'s operating margin in 2016?
In 2016, Biostar Pharmaceuticals, Inc.'s operating margin was -149.50%, compared with -87.57% in 2015.
How has Biostar Pharmaceuticals, Inc.'s operating margin changed since 2011?
From 2011 to 2016, Biostar Pharmaceuticals, Inc.'s operating margin was highest in 2011 (19.75%) and lowest in 2016 (-149.50%).
How does Biostar Pharmaceuticals, Inc.'s operating margin compare with similar companies?
Biostar Pharmaceuticals, Inc.'s operating margin (-149.50%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.